Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

electroCore, Inc. (ECOR)

$6.19 -2.75% NASDAQ: ECOR · 15-min delayed
  • ROCKAWAY, New Jersey
  • Public · NASDAQ: ECOR
  • 83 employees
$72.3MMarket cap
$32.0MRevenue · FY2025
-$14.0MNet income
83Employees
ECORNASDAQ
2018IPO

About electroCore, Inc.

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$32.0M
Net income
-$14.0M
Total assets
$18.7M
Market cap
$72.3M
Gross margin
86.8%
Operating margin
-41.1%
Net margin
-43.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$32.0M
Cost of revenue
$4.2M
Gross profit
$27.8M
Operating expenses
$40.9M
Operating income
-$13.2M
Income tax
$3.0K
Net income
-$14.0M
EPS (basic)
$-1.65
EPS (diluted)
$-1.65

Balance sheet

Total assets
$18.7M
Current assets
$15.7M
Total liabilities
$20.4M
Current liabilities
$11.3M
Shareholders’ equity
-$1.7M

Cash flow

Operating cash flow
-$8.2M
Investing cash flow
$3.9M
Financing cash flow
$7.6M
Net cash flow
$3.3M

Statements via Polygon.io (SEC filings)

NASDAQ: ECOR
$6.19 -2.75%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$4.31 $10.35

52-week range

Market cap
$72.3M
EPS (diluted)
$-1.65
Shares outstanding
11.7M
Open
Day range
Prev close
Volume
IPO date
Jun 22, 2018

electroCore, Inc. (ECOR) Stock Price

  • Reported a net loss of $14.0M in FY2025.
  • Revenue grew 488% from FY2021 to FY2025.
  • Gross margin of 86.8%, net margin -43.6%.
  • Trading 40% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review electroCore, Inc..

Write a review
Newsroom

News about electroCore, Inc.

News & sentiment via Polygon.io

FAQ

electroCore, Inc.: frequently asked questions

Is electroCore, Inc. an American company?

electroCore, Inc. is a US-based company headquartered in Rockaway, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is electroCore, Inc. headquartered?

electroCore, Inc. is headquartered in Rockaway, New Jersey, United States.

Is electroCore, Inc. publicly traded?

Yes — electroCore, Inc. is a publicly traded company. Its stock trades under the ticker symbol ECOR on the NASDAQ.

What does electroCore, Inc. do?

electroCore, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →